AIBIOS
Irvine, CA
AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.
aibios.comCompany Details
Founded
- 2018
Employees
- Between 2 - 10 employees
Raised
- $4,608,029
Headquarters Location
- Irvine, CA
Public
- No
Acquired
- No
CEO
Akio Sato
Company Collections
These are collections AIBIOS is a part of. Click on the collection name to view similar companies.